Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
247.99
+58.02 (30.54%)
At close: Dec 5, 2025, 4:00 PM EST
251.25
+3.26 (1.31%)
After-hours: Dec 5, 2025, 7:59 PM EST
PRAX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 7.46 | 8.55 | 2.45 | - | - | - | |
| Revenue Growth (YoY) | 364.98% | 249.53% | - | - | - | - | |
| Cost of Revenue | 245.9 | 152.41 | 86.77 | 154.44 | - | - | |
| Gross Profit | -238.43 | -143.86 | -84.32 | -154.44 | - | - | |
| Selling, General & Admin | 54.68 | 56.31 | 42.05 | 59.55 | 47.08 | 16.99 | |
| Research & Development | - | - | - | - | 120.26 | 44.98 | |
| Operating Expenses | 54.68 | 56.31 | 42.05 | 59.55 | 167.33 | 61.97 | |
| Operating Income | -293.11 | -200.17 | -126.37 | -213.99 | -167.33 | -61.97 | |
| Interest & Investment Income | 15.06 | 12.34 | 3.14 | 1.96 | 2.36 | 0.14 | |
| EBT Excluding Unusual Items | -278.05 | -187.83 | -123.23 | -212.03 | -164.97 | -61.83 | |
| Merger & Restructuring Charges | - | - | - | -1 | - | - | |
| Gain (Loss) on Sale of Investments | 5.01 | 5.01 | -0.05 | -1 | -2.09 | - | |
| Pretax Income | -273.04 | -182.82 | -123.28 | -214.03 | -167.06 | -61.83 | |
| Income Tax Expense | - | - | - | - | - | -0.01 | |
| Net Income | -273.04 | -182.82 | -123.28 | -214.03 | -167.06 | -61.82 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 8.5 | |
| Net Income to Common | -273.04 | -182.82 | -123.28 | -214.03 | -167.06 | -70.32 | |
| Shares Outstanding (Basic) | 21 | 18 | 7 | 3 | 3 | 1 | |
| Shares Outstanding (Diluted) | 21 | 18 | 7 | 3 | 3 | 1 | |
| Shares Change (YoY) | 39.19% | 171.55% | 114.58% | 8.58% | 374.34% | 485.12% | |
| EPS (Basic) | -12.92 | -10.21 | -18.69 | -69.65 | -59.03 | -117.86 | |
| EPS (Diluted) | -12.92 | -10.21 | -18.69 | -69.65 | -59.03 | -117.86 | |
| Free Cash Flow | -228.92 | -131.76 | -111.19 | -185.49 | -125.6 | -52.62 | |
| Free Cash Flow Per Share | -10.84 | -7.36 | -16.86 | -60.36 | -44.38 | -88.19 | |
| Operating Margin | -3927.51% | -2340.29% | -5164.40% | - | - | - | |
| Profit Margin | -3658.53% | -2137.48% | -5037.88% | - | - | - | |
| Free Cash Flow Margin | -3067.41% | -1540.48% | -4543.77% | - | - | - | |
| EBITDA | -292.95 | -199.81 | -125.94 | -213.57 | -167.15 | -61.92 | |
| D&A For EBITDA | 0.16 | 0.36 | 0.43 | 0.42 | 0.18 | 0.05 | |
| EBIT | -293.11 | -200.17 | -126.37 | -213.99 | -167.33 | -61.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.